XTRA:SY1Chemicals
Symrise (XTRA:SY1): Exploring Valuation After Q3 2025 Sales Growth and Outlook Update
Symrise (XTRA:SY1) shared its third quarter 2025 sales results, reporting organic growth of 1.4% despite tough year-on-year comparisons and the impacts of portfolio changes and currency fluctuations. Investors are watching how sustained project activity influences outlook.
See our latest analysis for Symrise.
Symrise shares are down 28.3% year-to-date, while the total shareholder return over the past year has dipped 32.8%. The latest positive sales update and a strong project pipeline have...